These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27720259)

  • 1. TGF-β1 promotes linear invadosome formation in hepatocellular carcinoma cells, through DDR1 up-regulation and collagen I cross-linking.
    Ezzoukhry Z; Henriet E; Piquet L; Boyé K; Bioulac-Sage P; Balabaud C; Couchy G; Zucman-Rossi J; Moreau V; Saltel F
    Eur J Cell Biol; 2016 Nov; 95(11):503-512. PubMed ID: 27720259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discoidin domain receptor 1 controls linear invadosome formation via a Cdc42-Tuba pathway.
    Juin A; Di Martino J; Leitinger B; Henriet E; Gary AS; Paysan L; Bomo J; Baffet G; Gauthier-Rouvière C; Rosenbaum J; Moreau V; Saltel F
    J Cell Biol; 2014 Nov; 207(4):517-33. PubMed ID: 25422375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related modifications of type I collagen impair DDR1-induced apoptosis in non-invasive breast carcinoma cells.
    Saby C; Rammal H; Magnien K; Buache E; Brassart-Pasco S; Van-Gulick L; Jeannesson P; Maquoi E; Morjani H
    Cell Adh Migr; 2018; 12(4):335-347. PubMed ID: 29733741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of transmembrane receptor tyrosine kinase DDR1-STAT3 cascade by extracellular matrix remodeling promotes liver metastatic colonization in uveal melanoma.
    Dai W; Liu S; Wang S; Zhao L; Yang X; Zhou J; Wang Y; Zhang J; Zhang P; Ding K; Li Y; Pan J
    Signal Transduct Target Ther; 2021 May; 6(1):176. PubMed ID: 33976105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of DDR1 reduces invasive features of human A375 melanoma, HT29 colon carcinoma and SK-HEP hepatoma cells.
    Romayor I; Badiola I; Olaso E
    Cell Adh Migr; 2020 Dec; 14(1):69-81. PubMed ID: 32090682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate stiffness promotes latent TGF-β1 activation in hepatocellular carcinoma.
    Pang M; Teng Y; Huang J; Yuan Y; Lin F; Xiong C
    Biochem Biophys Res Commun; 2017 Jan; 483(1):553-558. PubMed ID: 28025149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.
    Zhong M; Zhong C; Cui W; Wang G; Zheng G; Li L; Zhang J; Ren R; Gao H; Wang T; Li X; Che J; Gohda E
    BMC Cancer; 2019 May; 19(1):439. PubMed ID: 31088527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysyl oxidase like 4, a novel target gene of TGF-beta1 signaling, can negatively regulate TGF-beta1-induced cell motility in PLC/PRF/5 hepatoma cells.
    Kim DJ; Lee DC; Yang SJ; Lee JJ; Bae EM; Kim DM; Min SH; Kim SJ; Kang DC; Sang BC; Myung PK; Park KC; Yeom YI
    Biochem Biophys Res Commun; 2008 Sep; 373(4):521-7. PubMed ID: 18586005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuin 6 promotes transforming growth factor-β1/H2O2/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence.
    Feng XX; Luo J; Liu M; Yan W; Zhou ZZ; Xia YJ; Tu W; Li PY; Feng ZH; Tian DA
    Cancer Sci; 2015 May; 106(5):559-66. PubMed ID: 25683165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDR1 is a Novel Biomarker and Potential Therapeutic Target for the Combination Treatment of Liver Hepatocellular Carcinoma.
    Li T; Hu H; Song Y; Shi Y; Hu D; Shen W; Ning B
    Cancer Control; 2024; 31():10732748241286257. PubMed ID: 39284684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal activation between MMP-8 and TGF-β1 stimulates EMT and malignant progression of hepatocellular carcinoma.
    Qin G; Luo M; Chen J; Dang Y; Chen G; Li L; Zeng J; Lu Y; Yang J
    Cancer Lett; 2016 Apr; 374(1):85-95. PubMed ID: 26872724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β
    Baltes F; Caspers J; Henze S; Schlesinger M; Bendas G
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells.
    Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G
    Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-β1 gene expression in hepatocellular carcinoma: a preliminary report.
    Farid IM; Hamza IM; El-Abd DM; Mohyi AM; AbdulLatif MM; Aref AT; Hamza DM
    Arab J Gastroenterol; 2014; 15(3-4):142-7. PubMed ID: 25475758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis.
    Wei Y; Kim TJ; Peng DH; Duan D; Gibbons DL; Yamauchi M; Jackson JR; Le Saux CJ; Calhoun C; Peters J; Derynck R; Backes BJ; Chapman HA
    J Clin Invest; 2017 Oct; 127(10):3675-3688. PubMed ID: 28872461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming Growth Factor β1 Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells Via Up-Regulation of Connective Tissue Growth Factor.
    Liu H; Wang S; Ma W; Lu Y
    Cell Biochem Biophys; 2015 Dec; 73(3):775-81. PubMed ID: 27259324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway.
    Pan Y; Han M; Zhang X; He Y; Yuan C; Xiong Y; Li X; Zeng C; Lu K; Zhu H; Lu X; Liu Q; Liang H; Liao Z; Ding Z; Zhang Z; Chen X; Zhang W; Zhang B
    Cell Oncol (Dordr); 2022 Feb; 45(1):163-178. PubMed ID: 35089546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.